H. Lundbeck A/S

A key part of the H. Lundbeck A/S mission is to create partnerships with psychiatrists and neurologists that result in the improved treatment and hence improved quality of life for patients suffering from Central Nervous System disorders. As part of this commitment, the Lundbeck Institute was established in 1997, and is dedicated to educating physicians from around the world who are involved in treating CNS disorders.

H. Lundbeck A/S is a dynamically growing company with a strong financial track record. It has evolved from a Danish midsize enterprise in 1990 with around 1,000 employees to be a true global player with subsidiaries in more than 60 countries worldwide.  Today, more than 5,000 people work at H. Lundbeck A/S and its subsidiaries. 

The main focus of H. Lundbeck A/S is products and projects that expand their range of pharmaceuticals for the treatment of diseases of, or associated with, the central nervous system.

H. Lundbeck A/S is working intensely to find and develop new and improved drugs. The company believes that it can make a significant difference, and is happy to do so in cooperation with others.